After A COVID-19 Vaccine: Collaboration Or Competition?

Meyer, Harris

Meyer, Harris.

Meyer H; The Health Affairs symposium described in this article was supported by Anthem Inc., Amgen Inc., Avalere, Kaiser Permanente, Pharmaceutical Research and Manufacturers of America (PhRMA), Gilead, McKesson, Quest Diagnostics, Dynavax, Alexion, and Danaher. Harris Meyer (harris_meyer@yahoo.com) is a freelance writer based in Chicago, Illinois. [Published online September 28, 2020.].

Health Aff (Millwood) ; 39(11): 1856-1860, 2020 11.

Article in English | MEDLINE | ID: covidwho-806991

ABSTRACT

ABSTRACT

As COVID-19 vaccines and therapies emerge, critical questions remain about access and affordability around the world.

Subject(s)

Betacoronavirus/isolation & purification; Cooperative Behavior; Coronavirus Infections; International Agencies; Mass Vaccination/standards; Pandemics; Pneumonia, Viral; Viral Vaccines; COVID-19; COVID-19 Vaccines; Coronavirus Infections/prevention & control; Humans; SARS-CoV-2; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / International Agencies / Viral Vaccines / Mass Vaccination / Coronavirus Infections / Cooperative Behavior / Pandemics / Betacoronavirus Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Health Aff (Millwood) Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google